PTPN12
Tyrosine-protein phosphatase non-receptor type 12
Also known as: PTN12_HUMAN, PTP-PEST, PTPG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q05209
- Gene
- PTPN12
- Ensembl
- ENSG00000127947
- Chromosome
- 7
- Canonical length
- 780 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains a C-terminal PEST motif, which serves as a protein-protein interaction domain, and may regulate protein intracellular half-life. This PTP was found to bind and dephosphorylate the product of the oncogene c-ABL and thus may play a role in oncogenesis. This PTP was also shown to interact with, and dephosphorylate, various products related to cytoskeletal structure and cell adhesion, such as p130 (Cas), CAKbeta/PTK2B, PSTPIP1, and paxillin. This suggests it has a regulatory role in controlling cell shape and mobility. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
780 residues, UniProt reviewed canonical sequence.
>Q05209|PTPN12
1 MEQVEILRKF IQRVQAMKSP DHNGEDNFAR DFMRLRRLST KYRTEKIYPT ATGEKEENVK
61 KNRYKDILPF DHSRVKLTLK TPSQDSDYIN ANFIKGVYGP KAYVATQGPL ANTVIDFWRM
121 IWEYNVVIIV MACREFEMGR KKCERYWPLY GEDPITFAPF KISCEDEQAR TDYFIRTLLL
181 EFQNESRRLY QFHYVNWPDH DVPSSFDSIL DMISLMRKYQ EHEDVPICIH CSAGCGRTGA
241 ICAIDYTWNL LKAGKIPEEF NVFNLIQEMR TQRHSAVQTK EQYELVHRAI AQLFEKQLQL
301 YEIHGAQKIA DGVNEINTEN MVSSIEPEKQ DSPPPKPPRT RSCLVEGDAK EEILQPPEPH
361 PVPPILTPSP PSAFPTVTTV WQDNDRYHPK PVLHMVSSEQ HSADLNRNYS KSTELPGKNE
421 STIEQIDKKL ERNLSFEIKK VPLQEGPKSF DGNTLLNRGH AIKIKSASPC IADKISKPQE
481 LSSDLNVGDT SQNSCVDCSV TQSNKVSVTP PEESQNSDTP PRPDRLPLDE KGHVTWSFHG
541 PENAIPIPDL SEGNSSDINY QTRKTVSLTP SPTTQVETPD LVDHDNTSPL FRTPLSFTNP
601 LHSDDSDSDE RNSDGAVTQN KTNISTASAT VSAATSTESI STRKVLPMSI ARHNIAGTTH
661 SGAEKDVDVS EDSPPPLPER TPESFVLASE HNTPVRSEWS ELQSQERSEQ KKSEGLITSE
721 NEKCDHPAGG IHYEMCIECP PTFSDKREQI SENPTEATDI GFGNRCGKPK GPRDPPSEWTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- placenta: 70 nTPM
- bone marrow: 66 nTPM
- lung: 62 nTPM
- adipose tissue: 58 nTPM
- blood vessel: 54 nTPM
- spleen: 50 nTPM
Single-cell type
- neutrophils: 2,007 nCPM
- platelets: 923 nCPM
- neutrophil progenitors: 662 nCPM
- myosatellite cells: 467 nCPM
- monocytes: 449 nCPM
- esophageal apical cells: 346 nCPM
Immune cell
- NK-cell: 13 nTPM
- neutrophil: 9.5 nTPM
- eosinophil: 6.8 nTPM
- non-classical monocyte: 5.3 nTPM
- classical monocyte: 4.1 nTPM
- myeloid DC: 3.8 nTPM
Brain region
- thalamus: 69 nTPM
- medulla oblongata: 61 nTPM
- cerebral cortex: 59 nTPM
- white matter: 59 nTPM
- cerebellum: 58 nTPM
- pons: 57 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTPN12.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 120 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on PTPN12 was assayed in.
- collecting duct carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to epidermal growth factor stimulus
- negative regulation of ERBB signaling pathway
- negative regulation of platelet-derived growth factor receptor-beta signaling pathway
- peptidyl-tyrosine dephosphorylation
- protein dephosphorylation
- regulation of epidermal growth factor receptor signaling pathway
- tissue regeneration
Molecular functions
- non-membrane spanning protein tyrosine phosphatase activity
- phosphoprotein phosphatase activity
- protein tyrosine phosphatase activity
- SH3 domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- Protein-tyrosine phosphatase, active site
- Protein-tyrosine phosphatase-like
- Tyrosine-protein phosphatase non-receptor type 12/18/22
- Protein-tyrosine phosphatase
- Tyrosine-protein phosphatase non-receptor type 12
- Protein-tyrosine phosphatase non-receptor type-12, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPN12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN12 as an antibody target. Whether an autoantibody or antibody against PTPN12 could matter depends on whether native PTPN12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN12 is annotated at the cell surface, where native PTPN12 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTPN12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...